Rixilta 500mg Injection

Rixilta 500mg Injection contains rituximab as its active constituent. It is used for several different disease conditions in adults. It is used alone or in combination with other medications to treat non-Hodgkin lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukaemia (a common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a disease in which the immune system attacks the body's own joint cells) in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals). Rixilta 500mg Injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredient of this medicine, have a weak immune system, or have any severe active infection. Inform your doctor if you have heart disease, heart failure, or breathing problems before starting treatment. Speak with your doctor if you have ever had hepatitis B infection because in some cases the infection may reactivate and can be severe. Pregnancy and breastfeeding are not recommended while taking this injection. Common side effects of Rixilta 500mg Injection include blood infection, reduced red blood cells, dizziness, facial and body swelling, itchy skin, diarrhoea, increased sweating, and low or high blood pressure. Use effective contraceptive methods during treatment and for 12 months after the last dose if you can become pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your doctor or healthcare professional if you experience any infusion reactions such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.

Non-hodgkin’s lymphoma (NHL) Chronic lymphocytic leukemia (CLL) Rheumatoid Arthritis Granulomatosis with polyangiitis or microscopic polyangiitis Pemphigus vulgaris

Rixilta 500mg Injection is a monoclonal antibody that targets the antigen CD20 expressed on the cell surface of B-lymphocytes (a type of white blood cells). When this medicine binds to the B-cell, it induces cell death in NHL and CLL. The binding action blocks cell activation and growth and causes anticancer effects. It inhibits rheumatoid factor production, antigen presentation, T-cell activation, and proinflammatory cytokine production in rheumatoid arthritis.

It should only be administered by a trained doctor or nurse. Do not self-administer the injection. Before giving Cytomab 100mg injection, you will be given other medications (pre-medication) to reduce the possible side effects. Your doctor will decide the dose and duration of your treatment based on the disease severity and other factors. It will be given as an intravenous infusion, and you will be monitored carefully for any unwanted side effects.

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious: Increased or decreased blood pressure Chest pain Hypersensitivity reactions Hepatitis B viral infection Memory loss, trouble thinking, difficulty in walking Common: Swelling in the face and body Diarrhea and nausea Itchy skin Anemia Muscle spasm Headache Urinary tract infection fever, chills, and shivering Inflammation of nasal cavities Cough, sore throat Loss of hair

Avoid vaccines before and during the therapy. Inform your physician if you have been vaccinated recently because Rixilta 500mg Injection may cause drug-induced immunosuppression. Report to your doctor immediately if you face any symptoms like chest pain, breathing difficulties, stomach pain, and skin reactions. There is limited information available on the safety of this medicine in renal failure patients; inform your physician if you have kidney disease. Vaccination with live virus vaccines is not recommended before or during the treatment for patients with rheumatoid arthritis. Inform your healthcare professional if you have any active infection during the treatment.